Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
957 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06690775 | CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | recruiting | Phase 2 | 230 | TORL Biotherapeutics, LLCINDUSTRY | 12 | Dec 23, 2025 | clinicaltrials |
| NCT06523608 | Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease(DETECT) | recruiting | — | 600 | University Hospital MuensterOTHER | 1 | Dec 22, 2025 |
| NCT06920680 | ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos | recruiting | — | 1,834 | Wuerzburg University HospitalOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT07059299 | A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma(NeoTISLEGA) | recruiting | Phase 1 | 18 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT05259605 | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | recruiting | — | 1,650 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Dec 17, 2025 | clinicaltrials |
| NCT06102057 | PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC(PACCELIO) | recruiting | Phase 2 | 110 | TheraOpOTHER | 2 | Dec 17, 2025 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT06898684 | Medulloblastoma Online Video-based Exercise Pilot Study(MOVE) | recruiting | N/A | 15 | Aron OnerupOTHER_GOV | 2 | Dec 16, 2025 | clinicaltrials |
| NCT05008809 | Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) | recruiting | Phase 3 | 507 | Dominik Paul ModestOTHER | 1 | Dec 12, 2025 | clinicaltrials |
| NCT06856837 | - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases | recruiting | Phase 2 | 140 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 2 | Dec 12, 2025 | clinicaltrials |
| NCT02863692 | Registry of the German CLL Study Group(CLL-Registry) | recruiting | — | 8,000 | German CLL Study GroupOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07148193 | Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)(PROSa+) | recruiting | — | 1,600 | Technische Universität DresdenOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT02417324 | International HIT-MED Registry (I-HIT-MED) | recruiting | — | 500 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT06201234 | Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer(ELEMENT) | recruiting | Phase 2 | 176 | GBG Forschungs GmbHOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT06440993 | Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | recruiting | Phase 2 | 42 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT06508775 | Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies(LONGSAFE) | recruiting | N/A | 40 | Miltenyi Biomedicine GmbHINDUSTRY | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07131956 | Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | recruiting | — | 200 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07216521 | Intent of Surgery for IPMN | recruiting | — | 2,000 | NYU Langone HealthOTHER | 5 | Oct 14, 2025 | clinicaltrials |
| NCT04644289 | WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC(WoO) | recruiting | Phase 2 | 60 | AGO Research GmbHINDUSTRY | 1 | Oct 3, 2025 | clinicaltrials |
| NCT07200453 | Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients | recruiting | N/A | 660 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT04111978 | MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)(MATAO) | recruiting | Phase 3 | 540 | Swiss GO Trial GroupNETWORK | 3 | Sep 29, 2025 | clinicaltrials |
| NCT05547919 | PSMA in Gastroenterologic Tumors (GIPSMA)(GIPSMA) | recruiting | N/A | 46 | Wuerzburg University HospitalOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT06708910 | AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI | recruiting | — | 460 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT04655066 | Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire | recruiting | — | 200 | St. Josefs-Hospital Wiesbaden GmbHOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT03396718 | De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas(DELPHI) | recruiting | N/A | 304 | Technische Universität DresdenOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05223413 | REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs(RESILIENCE) | recruiting | N/A | 608 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIOTHER | 6 | Sep 18, 2025 | clinicaltrials |
| NCT04892849 | Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy(ST-ICI02) | recruiting | — | 200 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT05658640 | HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies(HEM-iSMART D) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 15 | Sep 16, 2025 | clinicaltrials |
| NCT05745714 | HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART C) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT05751044 | HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART B) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT06133543 | Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer(RAISN) | recruiting | N/A | 44 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06144736 | PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND | recruiting | Phase 2 | 60 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05009082 | Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer | recruiting | Phase 3 | 970 | AGO Study GroupOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT04385290 | Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)(MOSAIC) | recruiting | Phase 1 / Phase 2 | 214 | Technische Universität DresdenOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT07159607 | Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)(APPEAR) | recruiting | — | 100 | LMU KlinikumOTHER | 2 | Sep 8, 2025 | clinicaltrials |
| NCT07156903 | Evaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer(PrähabPro) | recruiting | N/A | 60 | Charite University, Berlin, GermanyOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT04098146 | Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis | recruiting | — | 300 | AO Innovation Translation CenterOTHER | 8 | Sep 4, 2025 | clinicaltrials |
| NCT05180864 | Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer(OMEGA-2) | recruiting | N/A | 654 | Amsterdam UMCOTHER | 4 | Sep 4, 2025 | clinicaltrials |
| NCT06480266 | Influence of Protein Intake on Muscle Mass and Health-related Quality of Life During and After Radiotherapy(pROtein) | recruiting | — | 175 | Charite University, Berlin, GermanyOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT06490536 | The Sagittarius Trial | recruiting | Phase 3 | 700 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 3 | Aug 29, 2025 | clinicaltrials |
| NCT06784791 | Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)(NEOpredict-EGF) | recruiting | Phase 2 | 20 | University Hospital, EssenOTHER | 3 | Aug 29, 2025 | clinicaltrials |
| NCT03850574 | Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia(TUSCANY) | recruiting | Phase 1 / Phase 2 | 240 | Aptose Biosciences Inc.INDUSTRY | 6 | Aug 26, 2025 | clinicaltrials |
| NCT05538806 | TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study(TIGER Meso) | recruiting | — | 198 | NovoCure Ltd.INDUSTRY | 3 | Aug 22, 2025 | clinicaltrials |
| NCT07135817 | Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases(PRESTRASM) | recruiting | N/A | 20 | University Medical Center GoettingenOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07137819 | Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis(EXACT-1) | recruiting | Phase 3 | 280 | Aresus Pharma GmbHINDUSTRY | 1 | Aug 22, 2025 | clinicaltrials |
| NCT06887283 | Essen Amyloidosis Registry(EAR) | recruiting | — | 400 | University Hospital, EssenOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT07075016 | Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy(EVOLVE 1) | recruiting | Phase 3 | 227 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 16 | Aug 19, 2025 | clinicaltrials |
| NCT05583071 | Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL(MTR²) | recruiting | Phase 2 | 20 | University of CologneOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07118436 | Liquid Biopsy Under PSMA Radioligand Therapy(LOOPS) | recruiting | — | 100 | Wuerzburg University HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07111884 | GMMG Multiple Myeloma Registry | recruiting | — | 999 | Prof. Dr. Hartmut GoldschmidtOTHER | 1 | Aug 8, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials